Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
PRME
PRME
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PRME News
Avant Technologies Drives Gene Therapy Market to $36.55 Billion by 2032
Jan 02 2026
Newsfilter
Avant Technologies Drives Gene Therapy Market to $36.55 Billion by 2032
Jan 02 2026
PRnewswire
Prime Drink Group Closes $450,000 Non-Brokered Private Placement
Jan 01 2026
Globenewswire
PrimeDrink Group Plans Non-Brokered Private Placement to Raise Up to $5 Million
Dec 18 2025
Globenewswire
Prime Medicine Publishes Phase 1/2 Data for PM359, Demonstrating Significant Efficacy
Dec 07 2025
Globenewswire
Prime Medicine Publishes Phase 1/2 Data for PM359, Demonstrating Significant Efficacy
Dec 07 2025
Newsfilter
Prime Medicine to Showcase at Jefferies Global Healthcare Conference
Nov 11 2025
Newsfilter
Chardan Capital Keeps Buy Rating on Prime Medicine, Reduces Price Target to $9
Nov 10 2025
Benzinga
Prime Medicine Announces Financial Results for Q3 2025 and Shares Business Developments
Nov 07 2025
Newsfilter
My Leading Biotech Stock Selections and Investment Approach for the Coming 3-10 Years
Sep 18 2025
Benzinga
Cathie Wood Increases Holdings in Klarna, Synopsys, and Rubrik While Reducing Positions in Shopify and Roblox
Sep 11 2025
TipRanks
Cathie Wood Invests $1.9M in Biotech While Reducing Holdings in AI Stock PRME, TWST, TEM
Sep 10 2025
TipRanks
Macy's Raises FY2025 Forecast, Alongside REV Group, HealthEquity, Alphabet, and Other Major Stocks Gaining Ground on Wednesday
Sep 03 2025
Benzinga
Prime Medicine, Inc. (PRME) Shares Insights at Citi's Biopharma Back to School Conference Transcript
Sep 03 2025
Newsfilter
Chardan Capital Maintains Buy on Prime Medicine, Lowers Price Target to $10
Aug 08 2025
Benzinga
Cathie Wood Buys $69M Worth of Figma Stock on Blockbuster IPO Debut
Aug 01 2025
TipRanks
Show More News
